"Thymidine Phosphorylase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme that catalyzes the transfer of 2-deoxy-D-ribose from THYMIDINE to orthophosphate, thereby liberating thymidine.
| Descriptor ID |
D013939
|
| MeSH Number(s) |
D08.811.913.400.725.850.500 D23.050.301.500.600.925 D23.050.705.552.600.850
|
| Concept/Terms |
Thymidine Phosphorylase- Thymidine Phosphorylase
- Platelet-Derived Endothelial Cell Growth Factor
- Platelet Derived Endothelial Cell Growth Factor
- PD-ECGF
- Gliostatin
|
Below are MeSH descriptors whose meaning is more general than "Thymidine Phosphorylase".
Below are MeSH descriptors whose meaning is more specific than "Thymidine Phosphorylase".
This graph shows the total number of publications written about "Thymidine Phosphorylase" by people in this website by year, and whether "Thymidine Phosphorylase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2012 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thymidine Phosphorylase" by people in Profiles.
-
Bonotto M, Bozza C, Di Loreto C, Osa EO, Poletto E, Puglisi F. Making capecitabine targeted therapy for breast cancer: which is the role of thymidine phosphorylase? Clin Breast Cancer. 2013 Jun; 13(3):167-72.
-
Xia Q, Wang QW, Zhang JM. [Influence of interferon-a2a on thymidine phosphorylase expression and anticancer activity of 5'-deoxy-fluorouridine in human colon carcinoma cell lines LOVO and SW480]. Zhonghua Wei Chang Wai Ke Za Zhi. 2012 Jul; 15(7):719-22.
-
Myers T, Chengedza S, Lightfoot S, Pan Y, Dedmond D, Cole L, Tang Y, Benbrook DM. Flexible heteroarotinoid (Flex-Het) SHetA2 inhibits angiogenesis in vitro and in vivo. Invest New Drugs. 2009 Aug; 27(4):304-18.
-
Gilliam LK, Kohn AD, Lalani T, Swanson PE, Vasko V, Patel A, Livingston RB, Pickett CA. Capecitabine therapy for refractory metastatic thyroid carcinoma: a case series. Thyroid. 2006 Aug; 16(8):801-10.